Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9

被引:559
|
作者
Wu, Yuxuan [1 ]
Liang, Dan [1 ,2 ]
Wang, Yinghua [1 ,2 ]
Bai, Meizhu [1 ,3 ]
Tang, Wei [4 ]
Bao, Shiming [5 ]
Yan, Zhiqiang [5 ]
Li, Dangsheng [6 ]
Li, Jinsong [1 ,3 ]
机构
[1] Chinese Acad Sci, Shanghai Key Lab Mol Androl, Grp Epigenet Reprogramming,Shanghai Inst Biol Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Anim Core Facil, Shanghai 200031, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Lab Anim Ctr, Shanghai 201615, Peoples R China
[6] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China
基金
中国国家自然科学基金;
关键词
ONE-STEP GENERATION; CAS9; NUCLEASE; HUMAN-CELLS; GENOME; SYSTEM; MICE; SPECIFICITY; MUTATIONS; ELEGANS;
D O I
10.1016/j.stem.2013.10.016
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The CRISPR-Cas9 system has been employed to generate mutant alleles in a range of different organisms. However, so far there have not been reports of use of this system for efficient correction of a genetic disease. Here we show that mice with a dominant mutation in Crygc gene that causes cataracts could be rescued by coinjection into zygotes of Cas9 mRNA and a single-guide RNA (sgRNA) targeting the mutant allele. Correction occurred via homology-directed repair (HDR) based on an exogenously supplied oligonucleotide or the endogenous WT allele, with only rare evidence of off-target modifications. The resulting mice were fertile and able to transmit the corrected allele to their progeny. Thus, our study provides proof of principle for use of the CRISPR-Cas9 system to correct genetic disease.
引用
收藏
页码:659 / 662
页数:4
相关论文
共 50 条
  • [41] Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells
    Wu, Yuxuan
    Zhou, Hai
    Fan, Xiaoying
    Zhang, Ying
    Zhang, Man
    Wang, Yinghua
    Xie, Zhenfei
    Bai, Meizhu
    Yin, Qi
    Liang, Dan
    Tang, Wei
    Liao, Jiaoyang
    Zhou, Chikai
    Liu, Wujuan
    Zhu, Ping
    Guo, Hongshan
    Pan, Hong
    Wu, Chunlian
    Shi, Huijuan
    Wu, Ligang
    Tang, Fuchou
    Li, Jinsong
    CELL RESEARCH, 2015, 25 (01) : 67 - 79
  • [42] CRISPR-Cas9 technology: applications and human disease modelling
    Torres-Ruiz, Raul
    Rodriguez-Perales, Sandra
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2017, 16 (01) : 4 - 12
  • [43] Allergan dives into CRISPR-Cas9
    不详
    NATURE BIOTECHNOLOGY, 2017, 35 (04) : 296 - 296
  • [44] Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
    Cheong, Taek-Chin
    Compagno, Mara
    Chiarle, Roberto
    NATURE COMMUNICATIONS, 2016, 7
  • [45] CRISPR-Cas9: Power And Challenges
    Charpentier, Emmanuelle
    FASEB JOURNAL, 2016, 30
  • [46] CRISPR-Cas9 for muscle dystrophies
    Ballouhey, Oceane
    Bartoli, Marc
    Levy, Nicolas
    M S-MEDECINE SCIENCES, 2020, 36 (04): : 358 - 366
  • [47] CRISPR-Cas9 as a Trojan horse
    Monte, Daniel F. M.
    MOLECULAR THERAPY, 2023, 31 (10) : 2817 - 2818
  • [48] CRISPR-Cas9: Advances and Challenges
    Charpentier, E.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 766 - 766
  • [49] Characterization of CRISPR-Cas9 generated Pompe disease models
    Huang, Jeffrey Y.
    Grover, Abhinav
    Rangel, Anthony D.
    Wang, Raymond Y.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S66 - S67
  • [50] CRISPR-Cas9 application in mouse model creation and transcription regulation
    Wang, Haoyi
    TRANSGENIC RESEARCH, 2016, 25 (02) : 215 - 215